Salicylate treatment in Kawasaki disease: high dose or low dose?

[1]  D. Fulton,et al.  Effects of current therapy of Kawasaki disease on eicosanoid metabolism. , 1988, The American journal of cardiology.

[2]  G. Koren,et al.  Determinants of low serum concentrations of salicylates in patients with Kawasaki disease. , 1988, The Journal of pediatrics.

[3]  S. Miyazaki,et al.  Studies on the Effect of Long‐Term Use of Low Dose Aspirin in Kawasaki Disease , 1988, Acta paediatrica Japonica : Overseas edition.

[4]  J. Newburger,et al.  The treatment of Kawasaki syndrome with intravenous gamma globulin. , 1986 .

[5]  Y. Hamashima,et al.  Comparison of macroscopic, postmortem, angiographic and two-dimensional echocardiographic findings of coronary aneurysms in children with Kawasaki disease. , 1986, The American journal of cardiology.

[6]  G. Koren,et al.  775 PROBABLE EFFICACY OF HIGH DOSE SALICYLATE IN REDUCING CORONARY INVOLVEMENT IN KAWASAKI DISEASE , 1985, Pediatric Research.

[7]  G. Koren,et al.  Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease. , 1984, The Journal of pediatrics.

[8]  J. Burns,et al.  Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms. , 1984, The Journal of pediatrics.

[9]  Y. Sasaguri,et al.  Regression of aneurysms in Kawasaki disease: a pathological study. , 1982, The Journal of pediatrics.

[10]  S. Heptinstall,et al.  DIFFERENTIAL INHIBITION BY LOW-DOSE ASPIRIN OF HUMAN VENOUS PROSTACYCLIN SYNTHESIS AND PLATELET THROMBOXANE SYNTHESIS , 1981, The Lancet.

[11]  Y. Hamashima,et al.  Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes. , 1979, Japanese circulation journal.

[12]  S. Koike,et al.  Kawasaki disease: effect of treatment on coronary artery involvement. , 1979, Pediatrics.

[13]  P. Majerus,et al.  Inhibition of platelet prostaglandin synthetase by oral aspirin. , 1978, The Journal of clinical investigation.

[14]  H. Kato,et al.  Kawasaki disease: cardiac problems and management. , 1988, Pediatrics in review.

[15]  M. Takahashi,et al.  Can consensus be reached in cardiac management of Kawasaki syndrome? Review of a survey among Japanese and U.S. pediatric cardiologists. , 1987, Progress in clinical and biological research.

[16]  M. Yamamoto,et al.  Increased synthesis of thromboxane A2 by platelets from patients with Kawasaki disease. , 1983, The Journal of pediatrics.

[17]  H. Kato,et al.  Aspirin treatment and platelet function in Kawasaki disease. , 1980, The Kurume medical journal.

[18]  J. Jacobs.  Salicylate treatment of epidemic Kawasaki disease in New York City. , 1979, Therapeutic drug monitoring.